TWI680468B - Health management and consulting system with genetic testing - Google Patents

Health management and consulting system with genetic testing Download PDF

Info

Publication number
TWI680468B
TWI680468B TW106144393A TW106144393A TWI680468B TW I680468 B TWI680468 B TW I680468B TW 106144393 A TW106144393 A TW 106144393A TW 106144393 A TW106144393 A TW 106144393A TW I680468 B TWI680468 B TW I680468B
Authority
TW
Taiwan
Prior art keywords
data
individual
health management
consultation
genetic
Prior art date
Application number
TW106144393A
Other languages
Chinese (zh)
Other versions
TW201928992A (en
Inventor
陳怡芳
熊思愷
Original Assignee
達易特基因科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 達易特基因科技股份有限公司 filed Critical 達易特基因科技股份有限公司
Priority to TW106144393A priority Critical patent/TWI680468B/en
Publication of TW201928992A publication Critical patent/TW201928992A/en
Application granted granted Critical
Publication of TWI680468B publication Critical patent/TWI680468B/en

Links

Landscapes

  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

一種結合基因檢測之健康管理及諮詢系統,包含有一互動裝置、一資料庫、以及一運算中心。該互動裝置其包含有一輸入介面,以及一展示介面。該資料庫儲存有複數風險疾病特徵,複數風險疾病項目,以及複數諮詢建議資料。該運算中心具有一基因鑑測資料,一日常生理資料,以及一病歷資料,其中該運算中心依據該基因鑑測資料、該日常生理資料、以及該病歷資料,對照是否對應每一該風險疾病特徵,以取得匹配於該些風險疾病特徵之至少一該風險疾病項目以及至少一該諮詢建議資料,再傳送該些風險疾病項目、該些諮詢建議資料至該展示介面。A health management and consultation system incorporating genetic testing includes an interactive device, a database, and a computing center. The interactive device includes an input interface and a display interface. The database stores multiple risk disease characteristics, multiple risk disease items, and multiple counseling recommendations. The computing center has a genetic test data, a daily physiological data, and a medical history data, wherein the computing center checks whether it corresponds to each characteristic of the risk disease based on the genetic test data, the daily physiological data, and the medical history data. To obtain at least one risk disease item and at least one consultation suggestion data matching the characteristics of the risk disease, and then transmit the risk disease items and the consultation suggestion data to the display interface.

Description

結合基因檢測之健康管理及諮詢系統Health management and consulting system with genetic testing

本發明有關於一種結合基因檢測之健康管理及諮詢系統,尤指一種由受測者先天基因狀況及後天作息進行綜合評估並動態追蹤以提示使用者是否患有疾病風險之結合基因檢測之健康管理及諮詢系統。 The invention relates to a health management and consultation system combining genetic testing, and in particular to a health management combining genetic testing and comprehensive tracking of a subject's innate genetic status and acquired work schedule to prompt the user whether or not he / she has a disease risk And consulting systems.

鑒於基因鑑別技術日漸成熟,促成了現代預防醫學之發展。基因鑑別檢測能藉由比對統計數據,對每位受測者的先天體質進行量化分析,此外,另一項疾病成因,即是後天的生活習慣。因此,如能綜合上述兩項先天後天資訊,便能在受測者的健康狀況發生問題前預先獲知風險所在,而能對疾病加以預防。現有的健康狀況分析過程中,仍有相當比例的資料源來自於諮詢,需要同時參考先天之基因組成,以及後天生活型態進行雙向考量,方能獲得較準確可靠之結果。另外,現有雲端運算及數據分析之技術日益成熟,而能實現預防醫學及個人化健康管理之目的。 In view of the maturity of gene identification technology, it has contributed to the development of modern preventive medicine. Genetic identification tests can quantify the congenital constitution of each subject by comparing statistical data. In addition, another cause of the disease is the acquired habits. Therefore, if the above-mentioned two kinds of innate information can be combined, it is possible to know the risk in advance before the health condition of the test subject occurs, and to prevent the disease. In the current health status analysis process, a considerable proportion of data sources still come from consultations. Two-way considerations must be made with reference to the genetic composition of the innate and the acquired life style in order to obtain more accurate and reliable results. In addition, existing cloud computing and data analysis technologies are becoming increasingly mature, and can achieve the goals of preventive medicine and personalized health management.

然而,現有的追蹤技術雖可達成以上目的,但目前因的雲端運算系統僅能將使用者之先天、後天生理狀況與既定之資料庫進行比對,在使用者與專家諮詢系統之間的對答過程,通常系使用問卷調查方式,並將調查結果與資料庫間進行查表對照,致使系統無法獲取更為個人化之詢答項目,此一缺失將影響其諮詢結果之準確性。是以,先前技術實有改善之必要。 However, although the existing tracking technology can achieve the above purpose, the current cloud computing system can only compare the innate and acquired physiological status of the user with the established database, and answer the question between the user and the expert consultation system. The process usually uses a questionnaire survey method and compares the survey results with the database to check the table, which makes the system unable to obtain more personalized answer items. This lack will affect the accuracy of its consultation results. Therefore, it is necessary to improve the previous technology.

本發明之目的,在於解決先前技術使用問卷調查方式無法確實取得受測者生理資訊之問題。 The purpose of the present invention is to solve the problem that the prior art cannot accurately obtain the physiological information of the subject using the questionnaire survey method.

為達上述目的,本發明提供一種結合基因檢測之健康管理及諮詢系統,用於提供一個體之健康管理相關建議,該結合基因檢測之健康管理及諮詢系統包含有一互動裝置、一資料庫、以及一運算中心。該互動裝置包含有一供該個體輸入資訊之輸入介面,以及一供該個體閱聽諮詢建議之展示介面。該資料庫儲存有複數與疾病相關聯之風險疾病特徵,複數對應至少一風險疾病特徵之風險疾病項目,以及複數分別對應每一該風險疾病項目之諮詢建議資料。該運算中心係資訊連接於該互動裝置與該資料庫,並具有一預先對該個體進行基因鑑別所取得之基因鑑測資料,一動態紀錄該個體生理資訊所取得之日常生理資料,以及一記載有該個體就診歷程所取得之病歷資料。其中該運算中心依據該基因鑑測資料、該日常生理資料、以及該病歷資料,對照是否對應每一該風險疾病特徵,以取得匹配於該些風險疾病特徵之至少一該風險疾病項目以及至少一該諮詢建議資料,再傳送該些風險疾病項目、該些諮詢建議資料至該展示介面。 To achieve the above object, the present invention provides a health management and counseling system incorporating genetic testing for providing a body health management related recommendation. The health management and counseling system incorporating genetic testing includes an interactive device, a database, and A computing center. The interactive device includes an input interface for the individual to input information, and a display interface for the individual to listen to consultation suggestions. The database stores a plurality of risk disease characteristics associated with the disease, a plurality of risk disease items corresponding to at least one risk disease characteristic, and a plurality of consultation advice data corresponding to each of the risk disease items, respectively. The computing center is information connected to the interactive device and the database, and has a genetic test data obtained by genetically identifying the individual in advance, a daily record of daily physiological data obtained from the physiological information of the individual, and a record. There is medical record data obtained during the individual's consultation. Wherein, the computing center checks whether it corresponds to each of the risk disease characteristics based on the genetic test data, the daily physiological data, and the medical record data to obtain at least one risk disease item and at least one matching the risk disease characteristics. The consultation proposal data, and then the risk disease items and the consultation proposal data are transmitted to the display interface.

進一步地,所述之結合基因檢測之健康管理及諮詢系統,更進一步包含有一資訊連接於該運算中心之解決方案平台,該運算中心傳送匹配後之該些風險疾病項目以及該些諮詢建議資料予該解決方案平台,並且該解決方案平台回傳一可展示於該展示介面之解決方案物件。 Further, the health management and consultation system combining genetic testing further includes a solution platform connected to the information center of the computing center, and the computing center transmits the matched risk disease items and the consultation information to the computing center. The solution platform, and the solution platform returns a solution object that can be displayed on the display interface.

進一步地,該解決方案物件相關於促進該個體健康之藥品、補充食品、器材、療程或課程。 Further, the solution article is related to medicines, supplements, equipment, treatments or courses that promote the individual's health.

進一步地,該互動裝置包含有一穿戴式裝置,用以記錄該個體之生理資訊並記錄於該日常生理資料。 Further, the interactive device includes a wearable device for recording physiological information of the individual and recording the daily physiological data.

進一步地,該運算中心導入人工智慧系統。 Further, the computing center introduces an artificial intelligence system.

進一步地,該互動裝置、該資料庫以及該運算中心設置於一雲端平台。 Further, the interactive device, the database and the computing center are set on a cloud platform.

進一步地,該互動裝置係為智慧型手機、平板電腦或筆記型電腦,該輸入介面以及該展示介面係整合於一行動應用程式內。 Further, the interactive device is a smart phone, a tablet computer or a notebook computer, and the input interface and the display interface are integrated into a mobile application.

是以,本發明較先前技術具有以下有益功效: Therefore, the present invention has the following beneficial effects over the prior art:

1.本發明提供使用者先天、後天兩方面之追蹤及醫療建議,且透過穿戴式生物資訊收集裝置,可動態地偵測使用者之運動量、心搏等資訊,並利用醫學資料庫、健康管理資料庫及使用者基因鑑別結果進行交互比對,進而得出最適合該使用者之生活方針或照護建議。 1. The invention provides users with innate and acquired tracking and medical advice, and through wearable biological information collection devices, it can dynamically detect the user's exercise volume, heart rate and other information, and use medical databases and health management. The database and the user's genetic identification results are compared to each other to obtain the life policy or care recommendations that are most suitable for the user.

100‧‧‧健康管理及諮詢系統 100‧‧‧Health Management and Consulting System

10‧‧‧互動裝置 10‧‧‧ Interactive Device

11‧‧‧輸入介面 11‧‧‧ input interface

12‧‧‧展示介面 12‧‧‧ Display interface

13‧‧‧穿戴式裝置 13‧‧‧ Wearable

20‧‧‧資料庫 20‧‧‧Database

30‧‧‧運算中心 30‧‧‧ Computing Center

40‧‧‧解決方案平台 40‧‧‧Solution Platform

41‧‧‧解決方案物件 41‧‧‧Solution Object

50‧‧‧雲端平台 50‧‧‧ Cloud Platform

圖1:為本發明第一實施態樣之系統架構圖。 FIG. 1 is a system architecture diagram of a first embodiment of the present invention.

圖2:為本發明第一實施態樣之操作流程圖。 FIG. 2 is a flowchart of the operation of the first embodiment of the present invention.

圖3:為本發明互動裝置之操作畫面示意圖。 FIG. 3 is a schematic diagram of an operation screen of an interactive device according to the present invention.

茲就本申請案的技術特徵暨操作方式舉數個較佳實施態樣,並配合圖示說明謹述於后,俾提供審查參閱。再者,本創作中之圖式,為便於說明其比例未必按實際比例繪製,圖式中之比例並不用以限制本創作所欲請求保護之範圍。 Here are some preferred implementation aspects of the technical features and operation methods of this application, which will be described later in conjunction with the illustrations, and provided for review and reference. Furthermore, the scale of the drawings in this creation is not necessarily drawn to the actual scale for the convenience of illustration. The scales in the drawings are not intended to limit the scope of protection claimed in this creation.

關於本發明之技術,請參照第1圖所示,本發明提供一種結合基因檢測之健康管理及諮詢系統100,用於提供一個體之健康管理相關建議。該結合基因檢測之健康管理及諮詢系統100包含有一互動裝置10、一資料庫20、以及一運算中心30。本發明結合基因檢測之健康管理及諮詢系統100可用於任何人,特別是慢性病患者尤為適合,透過基因鑑別取得使用者先天體質條件,以及長期追蹤使用者生理狀態,統合後提供相應之健康建議,能逐漸改善使用者之作息、飲食習慣等,令使用者更能掌握自身疾病或是健康狀 況。該互動裝置10可為智慧型手機、平板電腦或筆記型電腦,並透過一行動應用程式作為該互動裝置10與該運算中心30資訊交換之介面。該資料庫20以及該運算中心30可透過網際網路設置於一雲端平台50,藉此隨時更新資訊,並利於系統供應商進行修繕及維護。 Regarding the technology of the present invention, please refer to FIG. 1. The present invention provides a health management and consultation system 100 combining genetic testing for providing advice on a body's health management. The genetic management-integrated health management and consultation system 100 includes an interactive device 10, a database 20, and a computing center 30. The health management and counseling system 100 combined with genetic testing of the present invention can be used by anyone, especially patients with chronic diseases. It is particularly suitable to obtain the user's innate physical condition through genetic identification, and to track the user's physiological state for a long time, and provide corresponding health advice after integration. Can gradually improve the user's work schedule, eating habits, etc., so that users can better grasp their own diseases or health conditions condition. The interactive device 10 can be a smart phone, a tablet or a notebook computer, and a mobile application is used as an interface for information exchange between the interactive device 10 and the computing center 30. The database 20 and the computing center 30 can be set on a cloud platform 50 through the Internet, thereby updating the information at any time and facilitating system vendors for repair and maintenance.

更詳言之,該互動裝置10其包含有一供該個體輸入資訊之輸入介面11,以及一供該個體閱聽諮詢建議之展示介面12,該輸入介面11與該展示介面12均可透過該行動應用程式配合螢幕、觸控螢幕或鍵盤加以實現。此外,互動裝置10包含有一詢答模組,用以導引該個體經由該輸入介面11輸入健康相關問題。例如是否有頭暈、發燒、咳嗽症狀等……該詢答模組可被組態為被動提供該個體有關生理狀態之選項,或是依據該個體之生活作息,給予相應的選項提高詢答效率。此外,該互動裝置10亦可在該個體發生緊急狀況如昏迷、喪失意識時,向該個體以外之對象發出警報。 In more detail, the interactive device 10 includes an input interface 11 for the individual to input information, and a display interface 12 for the individual to listen to consultation suggestions. Both the input interface 11 and the display interface 12 can be accessed through the action. The app works with the screen, touch screen, or keyboard. In addition, the interactive device 10 includes a question answering module for guiding the individual to input health related questions through the input interface 11. For example, whether there are symptoms of dizziness, fever, cough, etc ... The question answering module can be configured to passively provide the individual with options regarding the physiological state, or according to the individual's life and rest, give the corresponding options to improve the answering efficiency. In addition, the interactive device 10 can also alert an object other than the individual when an emergency situation such as coma or loss of consciousness occurs in the individual.

該資料庫20儲存有複數與疾病相關聯之風險疾病特徵,複數對應至少一風險疾病特徵之風險疾病項目,以及複數分別對應每一該風險疾病項目之諮詢建議資料。該些風險疾病項目可為高血壓、糖尿病……等,每一該風險疾病項目均對應到一個由一個或數個該風險疾病特徵所組成之群組,如心律不整、血管壁薄、高血糖等等。且每一該諮詢建議資料為針對相應之該風險疾病項目之生活作息建議方案,例如定期定量運動,飲食計畫等等。該資料庫20內儲存之資料可由醫學研究單位、醫院、公共衛生相關組織提供並更新,以利使用者能更容易取得適當且具公信力之建議。本發明中,該資料庫20為專家系統資料庫20,內容可涵蓋內分泌、心血管、肝臟等疾病病徵。該資料庫20則涵蓋營養學、復健醫學等相關知識,作為與該個人化健康資料庫20交互比對及參照之基礎。 The database 20 stores a plurality of risk disease characteristics associated with a disease, a plurality of risk disease items corresponding to at least one risk disease characteristic, and a plurality of consultation advice data corresponding to each of the risk disease items, respectively. The risk disease items can be hypertension, diabetes, etc. Each risk disease item corresponds to a group composed of one or several characteristics of the risk disease, such as arrhythmia, thin blood vessel walls, and high blood sugar. and many more. In addition, each of the consultation and recommendation materials is a life and rest suggestion plan for the corresponding risk disease project, such as regular quantitative exercise, diet plan and so on. The data stored in the database 20 can be provided and updated by medical research units, hospitals, and public health related organizations, so that users can more easily obtain appropriate and credible recommendations. In the present invention, the database 20 is an expert system database 20, and its content may cover symptoms of diseases such as endocrine, cardiovascular, and liver. The database 20 includes related knowledge such as nutrition and rehabilitation medicine, and serves as a basis for interactive comparison and reference with the personalized health database 20.

該運算中心30係資訊連接於該互動裝置10與該資料庫20,本發明中,該運算中心30導入人工智慧系統,並具有一預先對該個體進行基因鑑別所取得之基因鑑測資料,一動態紀錄該個體生理資訊所取得之日常生理資料,以及一記載有該個體就診歷程所取得之病歷資料。該基因鑑測資料係針對數種常見遺傳性疾病、慢性疾病、癌症等疾病之好發性進行鑑測,並由其中挑選出風險較高。該日常生理資料則是透過穿戴式裝置13進行資料收集,如生物數據收集手環等,透過該等穿戴式裝置13可記錄該個體之體溫、心搏、睡眠狀況、呼吸等。該病歷資料係記錄該個體就診所得結果。 The computing center 30 is information connected to the interactive device 10 and the database 20. In the present invention, the computing center 30 introduces an artificial intelligence system and has a genetic test data obtained by performing genetic identification on the individual in advance. Dynamically record daily physiological data obtained from the individual's physiological information, and a record of medical records obtained from the individual's medical history. The genetic testing data were tested for the prevalence of several common genetic diseases, chronic diseases, cancer and other diseases, and selected from them for higher risk. The daily physiological data is collected through a wearable device 13, such as a biological data collection bracelet, etc., through which the body temperature, heartbeat, sleep status, breathing, etc. of the individual can be recorded. The medical record data records the individual's results at the clinic.

其中該運算中心30依據該基因鑑測資料、該日常生理資料、以及該病歷資料,對照是否對應每一該風險疾病特徵,以取得匹配於該些風險疾病特徵之至少一該風險疾病項目以及至少一該諮詢建議資料,再傳送該些風險疾病項目、該些諮詢建議資料至該展示介面12。 Wherein, the computing center 30 checks whether it corresponds to each of the risk disease characteristics based on the genetic testing data, the daily physiological data, and the medical record data to obtain at least one risk disease item matching the risk disease characteristics and at least one Once the consultation proposal data is transmitted, the risk disease items and the consultation proposal data are transmitted to the display interface 12.

此外,所述之結合基因檢測之健康管理及諮詢系統100,更進一步包含有一解決方案平台40。該解決方案平台40具體可為提供疾病照護、保健相關藥品、工具、療程或課程之機構或企業,該解決方案平台40係資訊連接於該互動裝置10、該運算中心30以及該資料庫20,該運算中心30傳送匹配後之該些風險疾病項目、該些諮詢建議資料至該解決方案平台40,令該解決方案平台40據以傳送一解決方案資訊予該互動裝置10之該展示介面12,並經由該展示介面12將該些諮詢建議資料轉化為類似廣告投放物件,同時達成分群廣告之目的。 In addition, the health management and consultation system 100 incorporating genetic testing further includes a solution platform 40. The solution platform 40 may specifically be an institution or enterprise providing disease care, health-related medicines, tools, courses or courses. The solution platform 40 is information connected to the interactive device 10, the computing center 30, and the database 20. The computing center 30 transmits the matched risk disease projects and the consulting suggestions to the solution platform 40, so that the solution platform 40 transmits a solution information to the display interface 12 of the interactive device 10, And through the display interface 12, the consulting suggestions are transformed into similar advertising objects, and the purpose of group advertisement is achieved at the same time.

以下舉例說明本發明之運作方式。參照第2圖所示,本發明之流程大致可分為以下步驟: The following examples illustrate the operation of the present invention. Referring to Figure 2, the process of the present invention can be roughly divided into the following steps:

步驟S1:該運算中心30依據該基因鑑測資料、該日常生理資料、以及該病歷資料列出數項相關於該個體之特徵。本步驟中,該運算中心30可運 用查表等方式比對預設的風險項目,該個體之特徵可如用餐時間不正、睡眠不足、睡眠中斷頻繁、運動量低、或是體溫變化頻繁等等。 Step S1: The computing center 30 lists several characteristics related to the individual according to the genetic test data, the daily physiological data, and the medical record data. In this step, the computing center 30 can be operated By comparing the preset risk items with a table or other methods, the individual's characteristics can be, for example, irregular meal times, insufficient sleep, frequent sleep interruptions, low exercise volume, or frequent changes in body temperature.

步驟S2:該運算中心30將該個體之特徵對照是否符合該資料庫20中每一該風險疾病特徵,如否,則回到先前步驟S1;如是,則接續下一步驟S3。 Step S2: The computing center 30 compares the characteristics of the individual with each of the risk disease characteristics in the database 20. If not, it returns to the previous step S1; if so, it continues to the next step S3.

步驟S3:取得匹配於該些風險疾病特徵之至少一該風險疾病項目以及至少一該諮詢建議資料。此一步驟仍由該運算中心30執行,並藉由該資料庫20中比對結果所得出之對應疾病進行相關建議諮詢,藉以改善該個體之日常飲食內容、運動習慣、後續醫療追蹤等。 Step S3: Obtain at least one item of the risk disease and at least one item of the consultation suggestion that match the characteristics of the risk diseases. This step is still performed by the computing center 30, and related suggestions and consultations are performed on the corresponding diseases obtained from the comparison results in the database 20, so as to improve the individual's daily diet content, exercise habits, and follow-up medical tracking.

步驟S4:聯繫該解決方案平台40,判斷該些相關建議諮詢是否有相對應之項目。若是,則接續步驟S41:由該解決方案平台40提供該解決方案物件41,並與該些相關建議諮詢一併進入步驟S5。若否,則直接進入最後步驟S5。該解決方案物件41可為文字或聲音訊息、圖像、影片或超連結物件。 Step S4: Contact the solution platform 40 to determine whether there are corresponding items for the related suggestions and consultations. If yes, proceed to step S41: the solution object 41 is provided by the solution platform 40, and proceeds to step S5 along with the related suggestions and consultations. If not, go directly to the final step S5. The solution object 41 may be a text or audio message, an image, a movie, or a hyperlink object.

步驟S5:將該些相關建議諮詢傳輸至該展示介面12(如步驟S41發生,則連帶該解決方案物件41一併傳輸至該展示介面12),以供該個體參考。以下將以數個實施例加以說明本案之執行方式。 Step S5: The related suggestions are transmitted to the display interface 12 (if step S41 occurs, the solution object 41 is also transmitted to the display interface 12) for reference by the individual. The following describes the implementation of this case with several examples.

《實施例1》 << Example 1 >>

假設該個體之基因鑑測資料中,高血壓基因(ACE、AGT)呈現高風險,其日常生理資料中血壓偏高、心搏數異常,且其病歷資料有總膽固醇、三酸甘油脂、血管硬化指數數據異常等情形。該評估單元將前述資料與該資料庫20中與疾病相關之內容比對後,得出數項關聯性較高之具有高風險疾病(中風、心肌梗塞等),並與該資料庫20比對,得出抑制前述高風險疾病之相關對應方針,如日常飲食內容、運動習慣、後續醫療追蹤等,此一過程可透過該互動裝置10實行。 Suppose that the genetic test data of this individual shows high risk of hypertension genes (ACE, AGT), high blood pressure, abnormal heart rate in daily physiological data, and total medical records of total cholesterol, triglyceride, blood vessels The hardening index data is abnormal. The evaluation unit compares the foregoing information with the disease-related content in the database 20, and obtains a number of high-risk diseases (stroke, myocardial infarction, etc.) with high correlation, and compares with the database 20 The corresponding corresponding policies for suppressing the aforementioned high-risk diseases, such as daily diet content, exercise habits, follow-up medical tracking, etc., are obtained, and this process can be implemented through the interactive device 10.

《實施例2》 << Example 2 >>

假設該個體之基因鑑測資料中,代謝症候群基因分析(ADRB3)高呈現高風險,其日常生理資料中有血糖值偏高、BMI值偏高、運動量不足(動態數據)等現象,且其病歷資料有餐前血糖、醣化血色素等數據異常等情形。該評估單元將前述資料與該資料庫20中與疾病相關之內容比對後,得出數項關聯性較高之具有高風險之代謝性疾病如:糖尿病、腎臟病變等,並與該資料庫20比對,得出抑制前述高風險疾病之相關對應方針,如由前項比對結果所得出之對應疾病進行相關建議諮詢,藉以改善該個體之日常飲食內容、運動習慣、後續醫療追蹤等。此一實施例與前一例之間,所分析出之疾病不同,但會產生類似之諮詢建議。 Assume that in the genetic testing data of this individual, the metabolic syndrome gene analysis (ADRB3) presents a high risk. Its daily physiological data includes high blood glucose values, high BMI values, insufficient exercise (dynamic data), and other medical records. The data includes abnormal data such as pre-meal blood glucose and glycated hemoglobin. The evaluation unit compares the foregoing information with the disease-related content in the database 20, and obtains a number of high-risk metabolic diseases with high relevance, such as diabetes and kidney disease, and compares them with the database. 20 comparisons, to obtain the corresponding corresponding policies to suppress the aforementioned high-risk diseases, such as the relevant diseases obtained from the results of the previous comparison of related counseling, to improve the individual's daily diet content, exercise habits, follow-up medical tracking, etc. The disease analyzed between this embodiment and the previous one is different, but similar consultation suggestions will be generated.

《實施例3》 "Example 3"

假設該個體之基因鑑測資料中,肝癌及肝臟代謝基因分析(EGF、CYPD2)呈現高風險,其日常生理資料中有血糖值偏高、BMI值偏高、運動量低、作息不規律(動態數據)等現象,且其病歷資料有肝臟功能、胎兒甲型蛋白等數據異常等情形。該評估單元將前述資料與該資料庫20中與疾病相關之內容比對後,得出數項關聯性較高之具有高風險之肝臟疾病如:(肝臟疾病:脂肪肝酒精性肝炎等等,並與該資料庫20比對,得出抑制前述高風險疾病之相關對應方針,如由前項比對結果所得出之對應疾病進行相關諮詢,如避免酒精、提高運動習慣等建議。此一實施例與前一例之間,兩者之日常生理資料有所重疊,但仍有「作息不規律」之差異項目,可見若僅後天生活習慣進行諮詢,卻未進行基因分析,兩者其所得到的健康資訊便無法得到差異化之結果,而無法提供使用者最合適之諮詢建議。 Assume that in the genetic test data of this individual, liver cancer and liver metabolic gene analysis (EGF, CYPD2) present a high risk, and its daily physiological data includes high blood glucose values, high BMI values, low exercise volume, and irregular schedules (dynamic data ), Etc., and its medical records include abnormalities such as liver function and fetal alpha protein. The evaluation unit compares the foregoing information with the disease-related content in the database 20, and obtains several highly relevant liver diseases with high risk, such as: (liver disease: fatty liver alcoholic hepatitis, etc. And compare with the database 20 to get the relevant corresponding policies for suppressing the aforementioned high-risk diseases, such as consulting about the corresponding diseases obtained from the previous comparison results, such as suggestions for avoiding alcohol and improving exercise habits. This embodiment Compared with the previous case, the daily physiological data of the two overlap, but there are still differences in the "irregular schedule". It can be seen that if only the acquired habits are consulted but genetic analysis is not performed, the health of the two will be obtained. The information cannot obtain differentiated results, and cannot provide users with the most appropriate advice.

綜上所述,本發明提供使用者先天、後天兩方面之追蹤及醫療建議,且透過穿戴式生物資訊收集裝置,可動態地偵測使用者之運動量、心搏等資 訊,並利用醫學資料庫20、健康管理資料庫20及使用者基因鑑別結果進行交互比對,進而得出最適合該使用者之生活方針或照護建議。 In summary, the present invention provides users with innate and acquired tracking and medical advice, and through wearable biological information collection devices, it can dynamically detect the user's exercise volume, heart rate, and other information. Information, and use the medical database 20, health management database 20, and user genetic identification results to perform an interactive comparison to obtain the most suitable life policy or care recommendations for the user.

以上已詳細說明本創作之內容,惟以上所述者,僅為本創作之較佳實施例而已,當不能以此限定本創作實施之範圍,即凡依本創作申請專利範圍所作之均等變化與修飾,皆應仍屬本創作之專利涵蓋範圍內。 The content of this creation has been described in detail above, but the above are only the preferred embodiments of this creation. When the scope of implementation of this creation cannot be limited by this, that is, all equal changes and changes made in accordance with the scope of the patent application for this creation Modifications should still be covered by the patent of this creation.

Claims (6)

一種結合基因檢測之健康管理及諮詢系統,用於提供一個體之健康管理相關建議,該結合基因檢測之健康管理及諮詢系統包含有:一互動裝置,其包含有一供該個體輸入資訊之輸入介面,以及一供該個體閱聽諮詢建議之展示介面;一資料庫,儲存有複數與疾病相關聯之風險疾病特徵,複數對應至少一風險疾病特徵之風險疾病項目,以及複數分別對應每一該風險疾病項目之諮詢建議資料;以及一運算中心,係資訊連接於該互動裝置與該資料庫,並具有一預先對該個體進行基因鑑別所取得之基因鑑測資料,一動態紀錄該個體生理資訊所取得之日常生理資料,以及一記載有該個體就診歷程所取得之病歷資料,但未具有日常健康調查問卷的信息數據,其中該運算中心依據該基因鑑測資料、該日常生理資料、以及該病歷資料,但未包括該日常健康調查問卷的信息數據,對照是否對應每一該風險疾病特徵,以取得匹配於該些風險疾病特徵之至少一該風險疾病項目以及至少一該諮詢建議資料,再傳送該些風險疾病項目、該些諮詢建議資料至該展示介面;其中該運算中心導入人工智慧系統,並利用醫學資料庫、健康管理資料庫及使用者基因鑑別結果進行交互比對,進而得出最適合該使用者之生活方針或照護建議。A genetic management-related health management and consultation system is used to provide an individual's health management related advice. The genetic management-related health management and consultation system includes: an interactive device that includes an input interface for the individual to enter information , And a display interface for the individual to read and consult advice; a database storing a plurality of risk disease characteristics associated with the disease, a plurality of risk disease items corresponding to at least one risk disease characteristic, and a plurality of corresponding to each of the risks respectively Consultation and recommendation data for disease projects; and a computing center, which is connected to the interactive device and the database, and has genetic testing data obtained by genetic identification of the individual in advance, and a dynamic record of the individual's physiological information institute The daily physiological data obtained, and a record of the medical records obtained from the individual's medical history, but without the information data of the daily health questionnaire, wherein the computing center is based on the genetic test data, the daily physiological data, and the medical history Data, but not including the daily health questionnaire To obtain at least one risk disease item and at least one consultation suggestion data that match the characteristics of the risk diseases, and then transmit the risk disease items and the consultation suggestion data. To the display interface; where the computing center introduces an artificial intelligence system, and uses the medical database, health management database, and user genetic identification results to conduct an interactive comparison to obtain the most suitable life policy or care recommendations for the user. 如申請專利範圍第1項所述之結合基因檢測之健康管理及諮詢系統,更進一步包含有一資訊連接於該運算中心之解決方案平台,該運算中心傳送匹配後之該些風險疾病項目以及該些諮詢建議資料予該解決方案平台,並且該解決方案平台回傳一可展示於該展示介面之解決方案物件。As described in item 1 of the scope of the patent application, the health management and consultation system combining genetic testing further includes a solution platform connected to the computing center, and the computing center transmits the matched risk disease items and the The consulting information is provided to the solution platform, and the solution platform returns a solution object that can be displayed on the display interface. 如申請專利範圍第2項所述之結合基因檢測之健康管理及諮詢系統,其中該解決方案物件相關於促進該個體健康之藥品、補充食品、器材、療程或課程。The health management and counseling system incorporating genetic testing as described in item 2 of the scope of the patent application, wherein the solution object is related to medicines, supplementary foods, equipment, treatments or courses that promote the health of the individual. 如申請專利範圍第1項所述之結合基因檢測之健康管理及諮詢系統,其中該互動裝置包含有一穿戴式裝置,用以記錄該個體之生理資訊並記錄於該日常生理資料。The health management and counseling system incorporating genetic testing according to item 1 of the scope of the patent application, wherein the interactive device includes a wearable device for recording the physiological information of the individual and recording the daily physiological data. 如申請專利範圍第1項所述之結合基因檢測之健康管理及諮詢系統,其中該互動裝置、該資料庫以及該運算中心設置於一雲端平台。As described in item 1 of the scope of patent application, the health management and consultation system incorporating genetic testing, wherein the interactive device, the database and the computing center are set on a cloud platform. 如申請專利範圍第1項所述之結合基因檢測之健康管理及諮詢系統,其中該互動裝置係為智慧型手機、平板電腦或筆記型電腦,該輸入介面以及該展示介面係整合於一行動應用程式內。As described in item 1 of the scope of the patent application, the health management and consultation system incorporating genetic testing, wherein the interactive device is a smart phone, a tablet computer or a notebook computer, and the input interface and the display interface are integrated into a mobile application In-program.
TW106144393A 2017-12-18 2017-12-18 Health management and consulting system with genetic testing TWI680468B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW106144393A TWI680468B (en) 2017-12-18 2017-12-18 Health management and consulting system with genetic testing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106144393A TWI680468B (en) 2017-12-18 2017-12-18 Health management and consulting system with genetic testing

Publications (2)

Publication Number Publication Date
TW201928992A TW201928992A (en) 2019-07-16
TWI680468B true TWI680468B (en) 2019-12-21

Family

ID=68048748

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106144393A TWI680468B (en) 2017-12-18 2017-12-18 Health management and consulting system with genetic testing

Country Status (1)

Country Link
TW (1) TWI680468B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI808838B (en) * 2021-07-23 2023-07-11 高雄醫學大學 Clinical pharmaceutical treatment predicting and recommending system and method for evaluating the therapeutic efficacy of the second-generation hormonal therapy in prostate cancer

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112487287B (en) * 2020-11-26 2024-03-22 深圳韦格纳医学检验实验室 Method for recommending serious diseases by using gene detection result and questionnaire

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201232464A (en) * 2011-01-31 2012-08-01 Yuekang Healthcare Man Consultants Inc Online integrating system for anamnesis
CN105608340A (en) * 2016-03-16 2016-05-25 意滋尔健康科技(昆山)有限公司 Health management system based on cloud-computing data analysis
CN106096273A (en) * 2016-06-08 2016-11-09 江苏华康信息技术有限公司 A kind of disease symptoms derivation method based on TF IDF innovatory algorithm
CN107066791A (en) * 2016-12-19 2017-08-18 银江股份有限公司 A kind of aided disease diagnosis method based on patient's assay
TWM558438U (en) * 2017-12-18 2018-04-11 Gene Target Technology Co Ltd Health management and consulting system combined with gene inspection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201232464A (en) * 2011-01-31 2012-08-01 Yuekang Healthcare Man Consultants Inc Online integrating system for anamnesis
CN105608340A (en) * 2016-03-16 2016-05-25 意滋尔健康科技(昆山)有限公司 Health management system based on cloud-computing data analysis
CN106096273A (en) * 2016-06-08 2016-11-09 江苏华康信息技术有限公司 A kind of disease symptoms derivation method based on TF IDF innovatory algorithm
CN107066791A (en) * 2016-12-19 2017-08-18 银江股份有限公司 A kind of aided disease diagnosis method based on patient's assay
TWM558438U (en) * 2017-12-18 2018-04-11 Gene Target Technology Co Ltd Health management and consulting system combined with gene inspection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI808838B (en) * 2021-07-23 2023-07-11 高雄醫學大學 Clinical pharmaceutical treatment predicting and recommending system and method for evaluating the therapeutic efficacy of the second-generation hormonal therapy in prostate cancer

Also Published As

Publication number Publication date
TW201928992A (en) 2019-07-16

Similar Documents

Publication Publication Date Title
Curry et al. Screening for cardiovascular disease risk with electrocardiography: US preventive services task force recommendation statement
Saber et al. Distributional validity and prognostic power of the national institutes of health stroke scale in US administrative claims data
Wadhera et al. Disparities in care and mortality among homeless adults hospitalized for cardiovascular conditions
Li et al. A distributed ensemble approach for mining healthcare data under privacy constraints
Amarasingham et al. Clinical information technologies and inpatient outcomes: a multiple hospital study
Berger et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients
Sinnaeve et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non–ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events
Jha et al. The inverse relationship between mortality rates and performance in the Hospital Quality Alliance measures
Mitchell et al. Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment
Stewart et al. Twenty-six–year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study
Ruggiero et al. Medical assistant coaching to support diabetes self-care among low-income racial/ethnic minority populations: randomized controlled trial
Benn et al. Practical and ethical considerations of noninvasive prenatal diagnosis
Bowles et al. A comparison of in-person home care, home care with telephone contact and home care with telemonitoring for disease management
Lindenauer et al. Quality of care for patients hospitalized with heart failure: assessing the impact of hospitalists
Rosenbach et al. Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis
Jorde et al. Genetic ancestry testing: what is it and why is it important?
Kabra et al. Clinical outcomes of mortality, readmissions, and ischemic stroke among medicare patients undergoing left atrial appendage closure via implanted device
Lapham et al. Comparison of medical cannabis use reported on a confidential survey vs documented in the electronic health record among primary care patients
Sequist et al. Missed opportunities in the primary care management of early acute ischemic heart disease
Hill et al. What to do about the metabolic syndrome?
Schmaderer et al. Mobile health self-management interventions for patients with heart failure: a pilot study
Radler et al. Improvements in cardiometabolic risk factors among overweight and obese employees participating in a university worksite wellness program
Yu et al. Perinatal depression and risk of suicidal behavior
Pillay et al. Adiposity, body fat distribution, and risk of major stroke types among adults in the United Kingdom
TWI680468B (en) Health management and consulting system with genetic testing